65 Equity Partners

Pascal Heberling

Pascal is Co-Head of Europe and a Partner at 65 Equity Partners, based in London.

Pascal has over two decades private equity investing experience, latterly at BC Partners, where he was a Partner focusing on healthcare, and where he led the firm’s latest investment in CeramTec.

Prior to that, Pascal spent over six years at the Abu Dhabi Investment Authority (ADIA), in its private equity department, as Head of Healthcare and a member of its Executive Committee. During this time, Pascal led several investments including Galderma (Nestlé Skin Health), Pharmaceutical Product Development (PPD), and Moderna.

Previously, Pascal spent twelve years at Cinven, including nine years as a Partner, and where he played an integral role in a series of successful investments including Spire Healthcare, Numéricable, MediMedia, and Springer Science (today known as Springer Nature). He began his career in the mergers and acquisitions group of Merrill Lynch in London. He has served on numerous boards in his various roles.

Pascal is trilingual in English, French and German. He graduated summa cum laude from the Institut d’Études Politiques de Paris (Sciences Po) and holds an MA and an MBA from the University of Toronto (dean’s list).

Moses Tan

Moses Tan is a Legal Counsel at 65 Equity Partners, based in Singapore.

He joined 65 Equity Partners from Sidley Austin LLP, where his practice focused on mergers & acquisitions, private equity, joint ventures, corporate restructuring and general corporate and commercial matters. Moses has acted for a diverse range of sophisticated clients on large and complex cross-border transactions across a wide variety of industries.

Prior to joining Sidley, Moses worked at Allen & Gledhill LLP and WongPartnership LLP.

Moses holds a Bachelor of Laws (Second Class Honours (Upper)) from the National University of Singapore, and is admitted to the Singapore Bar.

Laura Yang

Laura Yang is a Vice President at 65 Equity Partners, based in Singapore.

Previously, Laura was an investment professional within Goldman Sach’s private equity team in London, focusing on power, utility and infrastructure investments. Prior to that she worked at CPP Investment Board in London focusing on real asset and infrastructure investments. She started her career within the Investment Banking Division of UBS.

Laura holds a Bachelor in Economics from University of Cambridge. She is fluent in English and Mandarin.

Andrew Lim

Andrew Lim is a board member of 65 Equity Partners, and a member of the Investment Committees

He is a Partner at Allen & Gledhill and a member of the firm’s Executive Committee. He has advised clients on numerous market-leading corporate and merger and acquisition transactions. He also advises clients on corporate governance, regulatory and compliance matters. His clients include MNCs, listed and non-listed companies, financial institutions and private equity firms.

Andrew was called to the Singapore Bar in 1986. He was an Associate with the Firm in 1988/89 before spending time as an investment banker. He rejoined the Firm in 1993 as a Partner.

Andrew serves as a Trustee on the Board of Trustees of the National University of Singapore and as a board member of Sentosa Development Corporation. He is a Director of Jurong Engineering Limited, Constellar Holdings Pte. Ltd., PIL Pte. Ltd, EDBI Pte. Ltd. and Weybourne Holdings Pte. Ltd. He is also a Fellow of the Singapore Institute of Directors, a member of the Legal Service Commission, and a member of the National University of Singapore Law Advisory Council

Andrew is consistently recognised for his leading expertise in various publications including Chambers Global, Chambers Asia-Pacific, IFLR1000, The Legal 500 Asia Pacific, Best Lawyers and Who’s Who Legal.